IP Library Granted Patent US 8,444,994
Granted Patent B2
US 8,444,994 · App. 12/999,132 · Granted May 21, 2013

Multivalent antihelminthic vaccine

Inventors: Peter Hotez (Bethesda, MD); Alexander Loukas (Cairns, AU); Mark Pearson (Buderim, AU); Jeffrey Bethony (Minas Gerais, BR); Bin Zhan (North Potomac, MD); Gaddam Goud (Boyds, MD); Maria Elena Bottazzi (Washington, DC); David Diemert (Washington, DC); Ami Shah Brown (Halethorpe, MD); Peter Giacomautonio (Mansfield, AU)
Assignees: The Albert B. Sabin Vaccine Institute; The George Washington University; The Council of the Queensland Institute of Medical Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,444,994
App. No.
12/999,132
Granted
May 21, 2013
Kind
B2
Abstract

A multivalent anthelmintic vaccine targets both hookworm and schistosomiasis. The vaccine includes, at a minimum, a recombinant third-stage larval hookworm antigen, a recombinant adult stage hookworm antigen, and a recombinant schistosome antigen. Preferably, the hookworm antigens are Necator americanus antigens, although antigens from other hookworm species (e.g. Ancylostoma duodenale ) may also be employed. The schistosome antigen is preferably a Schistosoma mansoni or a Schistosoma haematobium antigen although antigens from other schistosome species (e.g. Schistosoma japonicum ) may also be employed. In some cases full or partial sequences of schistosome antigens may be fused with full or partial sequences of hookworm { Necator americanus ) to produce recombinant chimeric antigens.

Claims (4)

1. A fusion protein including at least one amino acid sequence selected from the group consisting of SEQ ID NO:32, SEQ ID NO:34, and SEQ ID NO:36.

2. The fusion protein as recited in claim 1 , having the protein sequences of SEQ ID NO: 32.

3. The fusion protein as recited in claim 1 , having the protein sequences of SEQ ID NO: 34.

4. The fusion protein as recited in claim 1 , having the protein sequences of SEQ ID NO: 36.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2018
From: THE ALBERT B. SABIN VACCINE INSTITUTE, INC.
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 047380/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2012
From: LOUKAS, ALEXANDER; PEARSON, MARK; GIACOMANTONIO, PETER
To: THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
Reel/Frame 029501/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2012
From: HOTEZ, PETER; ZHAN, BIN; BOTTAZZI, MARIA ELENA
To: THE GEORGE WASHINGTON UNIVERSITY
Reel/Frame 029268/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2012
From: DIEMERT, DAVID; SHAH BROWN, AMI
To: THE ALBERT B. SABIN VACCINE INSTITUTE
Reel/Frame 029088/0470 →
Continuity (2)
Provisional Application 61077256 · Jul 1, 2008
Related Publication 20110200640A1 · Aug 18, 2011